GILEAD SCIENCES, INC. — Director's Dealing 2017

Sep 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-08-31

Reporting Person: Meyers James R (EVP Worldwide Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-31	Common Stock	M	60000	$21.00	Acquired	62715	Direct
2017-08-31	Common Stock	S	43300	$83.0142	Disposed	19415	Direct
2017-08-31	Common Stock	S	16700	$83.6392	Disposed	2715	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-31	Non-qualified Stock Option (Right to Buy)	$21.00	M	60000	Disposed	2017-10-22	Common Stock (60000)	Direct

Footnotes

F1: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F2: Sale prices reported for the transactions reported here range from $82.50 to $83.50. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F3: Sale prices reported for the transactions reported here range from $83.51 to $83.91. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.